| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0272-2712(18)30280-4 |
| P698 | PubMed publication ID | 8792083 |
| P2093 | author name string | Munoz SJ | |
| Rothstein KD | |||
| P2860 | cites work | Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV | Q27486078 |
| Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome | Q27860719 | ||
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| A pilot study of ribavirin therapy for chronic hepatitis C | Q28318414 | ||
| Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans | Q34195888 | ||
| Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. | Q34296050 | ||
| Response related factors in recombinant interferon alfa-2b treatment of chronic hepatitis C | Q34375913 | ||
| Ursodeoxycholic acid in chronic liver disease | Q37375835 | ||
| Enhanced expression of β 2 -microglobulin and HLA antigens on human lymphoid cells by interferon | Q37597245 | ||
| Molecular mechanisms of action of ribavirin | Q38016839 | ||
| Inhibition of human T lymphocyte function with monoclonal antibodies | Q40111043 | ||
| Therapy of Hepatitis C | Q40435919 | ||
| Hepatitis C: A Multifaceted Disease: Review of Extrahepatic Manifestations | Q40483846 | ||
| Gastrointestinal cytomegalovirus disease | Q40768858 | ||
| Pilot study of recombinant human alpha-interferon for chronic type B hepatitis | Q40811378 | ||
| Antiviral therapy of the Asian patient with chronic hepatitis B. | Q40812238 | ||
| Transplantation of hepatitis B immune lymphocytes as means for adoptive transfer of immunity to hepatitis B virus | Q40928671 | ||
| 16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection | Q41015489 | ||
| Hepatitis B x antigen and polymerase antibodies in the serum of hepatitis B carriers with or without hepatitis delta virus infection. Effects of interferon treatment | Q41108312 | ||
| Preliminary experience with alpha-2b-interferon therapy of viral hepatitis in liver allograft recipients | Q41127968 | ||
| Hepatitis C viral infection in liver transplant recipients | Q41812067 | ||
| Effect of Vidarabine on Chronic Hepatitis B Virus Infection | Q41828326 | ||
| Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial | Q41839327 | ||
| Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds. | Q41943886 | ||
| Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial | Q42008293 | ||
| Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver | Q42609313 | ||
| Long-term follow-up of patients with chronic hepatitis C treated with α-interferon | Q42981340 | ||
| Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus | Q42981586 | ||
| Hepatitis C virus infection in patients with essential mixed cryoglobulinemia | Q42981885 | ||
| The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients | Q42983268 | ||
| A role for hepatitis C virus infection in type II cryoglobulinemia | Q42983385 | ||
| Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B | Q70634960 | ||
| A preliminary trial of lamivudine for chronic hepatitis B infection | Q71523548 | ||
| Liver transplantation for hepatitis C: the promise and the challenge | Q71704797 | ||
| The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial | Q72302208 | ||
| Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver-transplant recipients | Q72305741 | ||
| Liver transplantation in European patients with the hepatitis B surface antigen | Q72623987 | ||
| Determination of human leukocyte populations involved in production of interferons alpha and gamma | Q72673964 | ||
| Serum markers of hepatic fibrogenesis in chronic hepatitis type C treated with alfa-2A interferon | Q72898769 | ||
| A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. | Q43036080 | ||
| Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy | Q43036833 | ||
| A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group | Q43039883 | ||
| Genotypic analysis of hepatitis C virus in American patients | Q43041871 | ||
| Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy | Q43048405 | ||
| Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon | Q43049218 | ||
| Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus | Q43049410 | ||
| Prednisolone in HBsAg-positive chronic active hepatitis: histologic evaluation in a controlled prospective study. | Q43762700 | ||
| Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis | Q43814867 | ||
| Interferon in viral hepatitis: role in pathogenesis and treatment | Q44001359 | ||
| Cellular immune response to HBcAg in mother-to-infant transmission of hepatitis B virus | Q44663428 | ||
| Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B. | Q44896392 | ||
| Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial | Q44998221 | ||
| Vertical Transmission of Hepatitis B Antigen in Taiwan | Q45146867 | ||
| Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization | Q45737135 | ||
| Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer | Q45783258 | ||
| The use of ampligen alone and in combination with ganciclovir and coumermycin A1 for the treatment of ducks congenitally-infected with duck hepatitis B virus | Q45786837 | ||
| X Region Deletion Variants of Hepatitis B Virus in Surface Antigen-Negative Infections and Non-A, Non-B Hepatitis | Q45787390 | ||
| Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers | Q45828013 | ||
| Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection | Q45839929 | ||
| A pilot study on the effects of prednisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B. | Q45848162 | ||
| Interferon antibodies may negate the antiviral effects of recombinant alpha-interferon treatment in patients with chronic hepatitis B virus infection | Q45849818 | ||
| Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis | Q45853314 | ||
| Recurrence of hepatitis C virus infection after orthotopic liver transplantation | Q45854351 | ||
| Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis | Q45886480 | ||
| Hepatitis C: and miles to go before we sleep | Q48934281 | ||
| Ribavirin treatment for chronic hepatitis C | Q50590272 | ||
| Effects of prednisolone pretreatment in interferon alfa therapy for patients with chronic non-A, non-B (C) hepatitis. | Q54052083 | ||
| N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study. | Q54234862 | ||
| LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTION | Q58236604 | ||
| Interferon-α increases prostaglandin E2 production by cultured liver biopsy in patients with chronic viral hepatitis: can non-steroidal anti-inflammatory drugs improve the therapeutic response to interferon? | Q61440976 | ||
| Pathogenesis of posttransfusion viral hepatitis in children with β-thalassemia | Q63236723 | ||
| Autoimmune chronic hepatitis exacerbated by alpha-interferon | Q67716313 | ||
| Alpha-Interferon Treatment of Chronic Hepatitis C: Need for Accurate Diagnosis in Selecting Patients | Q67716326 | ||
| Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-alpha | Q67882052 | ||
| Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients | Q68100857 | ||
| Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients | Q68295742 | ||
| A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group | Q68524263 | ||
| Inhibition of HBV DNA replication by ganciclovir in patients with AIDS | Q69375770 | ||
| Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B | Q69867331 | ||
| A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial | Q69989032 | ||
| Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis | Q69990988 | ||
| Long-term remission of chronic hepatitis B after alpha-interferon therapy | Q70117136 | ||
| Liver transplantation for patients with hepatitis B: what have we learned from our results? | Q70128712 | ||
| Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B | Q70214622 | ||
| Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report | Q70313812 | ||
| Interferon-associated retinopathy | Q70596182 | ||
| 2',5'-Oligoadenylate synthetase activity as a responsive marker during interferon therapy for chronic hepatitis C | Q70615550 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 465-491 | |
| P577 | publication date | 1996-06-01 | |
| P1433 | published in | Clinics in laboratory medicine | Q26841969 |
| P1476 | title | Interferon and other therapies for hepatitis B and hepatitis C infections | |
| P478 | volume | 16 |
| Q40909623 | A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice |
| Q43118529 | Construction, expression and characterization of human interferon alpha2b-(G4S)n-thymosin alpha1 fusion proteins in Pichia pastoris |
Search more.